DMH Ethics & Compliance Advisors – White Paper, October 2022

Enforcement Actions Against Companies Are Likely to Continue  – The Missing Element in Leadership Training

DMH Ethics & Compliance Advisors – White Paper, October 2021

The Strategic Approach to Ethics & Compliance Training You May Be Missing – And Why It Matters

DMH Ethics & Compliance Advisors – White Paper, March 2020

How to Keep Your Team Engaged During “Shelter at Home”

DMH Ethics & Compliance Advisors – White Paper, December 2018

“The Difference Between Ethics & Compliance”

DMH Ethics & Compliance Advisors – White Paper, October 2018

“The Missing Element in a Leader’s Decision Making Process.”

DMH Ethics & Compliance Advisors – White Paper, October 2018

“Is Your Ethics and Compliance Training Akin to a Revolving Hamster Wheel?  Why Behavioral Ethics is Key To Ethical Leadership Training and Value-Based Ethics Programs.“

DMH BioPharm Advisors – White Paper, June 2018

“FDA Issues Final Guidance on Drug and Device Manufacturer Communications with Payors, Formulary Committees, and Similar Entities.”

DMH BioPharm Advisors – White Paper, May 2018

“Prosecutor Panel Discusses Current Enforcement Trends at April 2018 Compliance Congress” 

DMH BioPharm Advisors – White Paper, January 2017

“FDA Issues Draft Guidance: Drug and Device Manufacturer Communications With Payors, Formulary Committees and Other Similar Entities”

DMH BioPharm Advisors – White Paper, January 2017

“21st Century Cures Act Draft Bill Update: Off-Label Information Dissemination and FDAMA 114”

DMH BioPharm Advisors – White Paper, February 2014

“Medical Affairs: Compliance Lessons Learned: Best Practices”

Rx Compliance Report, April 2011

“Commercial Compliance Training Needs to be a Collaborative Effort, Says Industry Veterans”

Focus Magazine, January 2011 (Winter Edition)

Focus Magazine is the quarterly magazine of the Society of Pharmaceutical and Biotech Trainers (SPBT) – Now known as Life Science Trainers & Educators Network (LTEN).

“Avoiding Mistakes That Can Derail Compliance Training”

Pharmaceutical Executive, September 2010

“Maintaining a Culture of Compliance”

Good Promotional Practices

DMH is a past contributing writer to the Good Promotional Practices;  a forum for establishing best collaborative practices in life sciences sales, marketing, compliance and regulatory functions.